Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2015 Apr 22;71(Pt 5):531–535. doi: 10.1107/S2056989015007331

Crystal structure of 3-bromo-2-hy­droxy­benzoic acid

Gerhard Laus a, Volker Kahlenberg b, Thomas Gelbrich a,*, Sven Nerdinger c, Herwig Schottenberger a
PMCID: PMC4420063  PMID: 25995873

Centrosymmetric dimers with a central Inline graphic(8) ring motif are formed as a result of (carbox­yl)O—H⋯O(carbox­yl) hydrogen bonds. In addition, there is an intra­molecular (hydrox­yl)O—H⋯O(carbox­yl) hydrogen-bonding inter­action.

Keywords: crystal structure, hydrogen bonding, structural systematics, XPac, salicylic acid derivative

Abstract

Mutual carbox­yl–carboxyl O—H⋯O hydrogen bonds link the mol­ecules of the title compound, C7H5BrO3, into centrosymmetric dimers which display a central R 2 2(8) ring motif. In addition, there is an intra­molecular hydrox­yl–carboxyl O—H⋯O inter­action present. A comparison with the crystal structures of 59 other substituted derivatives of salicylic acid shows that both the centrosymmetric carbox­yl–carboxyl O—H⋯O dimer and the stacking mode of mol­ecules along the short a axis observed in the title structure are frequent packing motifs in this set.

Chemical context  

Substituted derivatives of salicylic acid are widely used in organic synthesis and can be biologically active. Members of this class have served as model compounds for studies of crystal polymorphism (Sarma et al., 2010; Braun et al., 2011), the stability of hydrogen bonds (Bawa et al., 2004; Adam et al., 2010) or for systematic investigations of crystal-packing relationships (Montis & Hursthouse, 2012). The title compound is used in the synthesis of 7-bromo­benzoxazolin-2-one (Laus et al., 2011), which is an inter­mediate in the synthesis of bifeprunox, an experimental drug for the treatment of psychiatric disorders such as schizophrenia (Zwier et al., 2005; Eijgendaal et al., 2006).graphic file with name e-71-00531-scheme1.jpg

Structural commentary  

The mol­ecule is almost planar (Fig. 1). The plane defined by the non-H atoms of the carboxyl group is slightly twisted by 4.7 (4)° to the mean plane of the phenyl ring. An intra­molecular hydrogen bond, O1—H1⋯O3 (Table 1), connects the hydroxyl group bonded to C2 with the carboxyl group at C1.

Figure 1.

Figure 1

The mol­ecular structure of the title compound, drawn with displacement ellipsoids at the 50% probability level. H atoms are drawn as spheres of arbitrary size.

Table 1. Hydrogen-bond geometry (, ).

DHA DH HA D A DHA
O1H1O3 0.85(2) 1.88(4) 2.604(4) 142(5)
O2H2O3i 0.87(2) 1.80(2) 2.664(4) 172(6)

Symmetry code: (i) Inline graphic.

Supra­molecular features  

Neighbouring mol­ecules are linked to one another by a two-point O2—H2⋯O3(−x + 2, −y, −z + 1) connection involving a pair of anti­parallel inter­actions between their carboxyl groups (Fig. 2, Table 1). The resulting centrosymmetric dimer is described by the graph set Inline graphic(8) (Etter et al. 1990; Bernstein et al., 1995). In the crystal structure, the dimers, which are essentially planar units, assemble into slightly corrugated sheets which lie parallel to the (10Inline graphic) plane. A sheet of this kind contains a short C4—H4⋯O1(−x + Inline graphic, y + Inline graphic, −z + Inline graphic) contact (H⋯O = 2.57 Å, C—H⋯O = 145.7°) (Fig. 3 a) which involves the hydroxyl group at C2. The sheets are stacked in a parallel fashion in the a-axis direction with an inter­sheet separation of 3.798 (4) Å which corresponds to the length of this axis.

Figure 2.

Figure 2

Centrosymmetric dimer with a central Inline graphic(8) ring motif. Dashed lines indicate hydrogen bonds. [Symmetry code: (i) −x + 2, −y, −z + 1.]

Figure 3.

Figure 3

(a) Mol­ecular packing in the (10Inline graphic) plane. Dashed lines indicate O—H⋯O hydrogen bonds; C4—H4⋯O1(−x + Inline graphic, y + Inline graphic, −z + Inline graphic) contacts are indicated by thin dotted lines. Similar arrangements are present in the crystal structures of 3,5-Br and 3,5-Cl (supra­molecular construct S2). (b) Three corrugated sheets stacked in the a-axis direction.

Database survey  

A systematic study of packing motifs present in 24 crystal structures of monosubstituted derivatives of salicylic acid has previously been published by Montis & Hursthouse (2012), who also proposed a nomenclature where a substituent Rn at a ring position n (n = 3, 4, 5 or 6) is encoded n-Rn (Fig. 4; Rn ≠ H). The title compound of the present study is denoted 3-Br in this system. Our own survey of the Cambridge Structural Database (version 5.25; Groom & Allen, 2014) revealed 59 unique crystal structures of salicylic acid derivatives, listed in Table S1 of the Supporting information, which are close structural analogues of 3-Br. This set includes several polysubstituted derivatives as well as multiple-component crystals and crystal structures containing potential hydrogen bond donor and acceptor sites in addition to those of the 1-hydroxyl and 2-carboxyl groups.

Figure 4.

Figure 4

Scheme showing the general composition of substituted derivatives of salicylic acid, the crystal structures of which were compared in this study.

In order to establish the possible existence of geometrically similar substructure units, pairwise XPac comparisons (Gelbrich & Hursthouse, 2005) were carried out between the crystal structure of 3-Br on one hand and each of the other 59 salicylic acid derivatives on the other. Analogous to the study by Montis & Hursthouse (2012), the underlying calculations were based on the comparison of inter­molecular geometrical parameters generated from the ten non-H atomic positions of the salicylic acid mol­ecular core (C7O3) which is present in all compounds of the set. A qu­anti­tative descriptor, the dissimilarity index x 10 (Gelbrich et al., 2012), was calculated for each common supra­molecular construct (SC) identified. In general, a larger x 10 value indicates a lower degree of similarity and an x 10 value significantly higher than 10 is consistent with a situation where the fundamental features of a 3-Br substructure unit are also present in a second crystal, albeit with considerable geometrical modifications.

41 structures of the investigated set, including 3-Br, contain (carbox­yl)O—H⋯O(carbox­yl) hydrogen-bonded dimers with a central Inline graphic(8) ring motif (Fig. 2). All of the dimers are centrosymmetric, except for that of 3-COOH (Mereiter et al., 2001). In the latter structure, the Inline graphic(8) ring motif is inter­sected by a glide plane and connects the 2-carboxyl group of one mol­ecule with the 3-carboxyl group of the other so that an hydrogen-bonded chain structure is formed. Owing to the rigidity of the aromatic ring and the limited rotational flexibility about the C1—C7 bond, all 40 centrosymmetric dimers adopt approximately the same geometry, and the corres­ponding x 10 values are smaller than 12 (Table S1 of the Supporting information). In keeping with the nomenclature introduced by Montis & Hursthouse (2012), we denote this dimer SC A0.

A one-periodic SC, denoted X11 by Montis & Hursthouse (2012), describes the stacking of 3-Br mol­ecules along the shortest crystallographic axis [a axis; Fig. 5(right)]. We have identified another 21 examples of the same stacking mode (Table S1 of the Supporting Information) and the 13 best matches with x 10 > 12 are listed in Table 2. In this latter subset, the length of the stacking vector varies from 3.67 to 3.98 Å. Moreover, the eleven structures listed in the top section of Table 2 also contain a centrosymmetric dimer so that their common SC is actually a stack of dimers [denoted A11; Fig. 5(right)].

Figure 5.

Figure 5

(Left) Tree diagram illustrating the packing relationships between 3-Br and other substituted derivatives of salicylic acid. A number in a box indicates the number of crystal structures for which a given SC (A0, X11, A11 and S2) is the largest common SC with 3-Br. (Right) Instances of the SCs A0, X11, A11 in 3-Br.

Table 2. One-dimensional packing relationships between 3-Br and other derivatives of salicylic acid, based on the stacking of either individual molecules (X11) or dimers (A11) along the short crystallographic axis and identified with XPac .

Compound SCa x 10 b d ()c CSD code reference
3-Br A11 - 3.80 - This work
5-F A11 4.2 3.82 ABENEB Choudhury Guru Row (2004)
5-COOH A11 4.8 3.68 OJICEP Cox Murphy (2003)
3,4-OH0.25H2O A11 5.6 3.73 LAPZUZ Li et al. (2012)
5-OMe A11 5.6 3.98 VAXZUR Montis Hursthouse (2012)
5-Cl A11 7.1 3.71 VABVAX01 Montis Hursthouse (2012)
4-Cl A11 9.2 3.72 VAXYAW Montis Hursthouse (2012)
5-NO A11 9.5 3.67 NTSALA Talberg (1977)
4-NH2 A11 10.3 3.73 AMSALA02 Montis Hursthouse (2012)
4-OH A11 10.7 3.69 ZZZEEU04 Parkin et al. (2007)
4-Me A11 11.5 3.87 VAXYIE Montis Hursthouse (2012)
5-ACMH2O X11 2.2 3.75 VAXYOK Montis Hursthouse (2012)
5-CHO X11 5.6 3.78 UJOFEF Lu et al. (2010)
3-CHOH2O X11 11.1 3.72 JOHXEJ Claude et al. (1991)

Notes: (a) the largest supramolecular construct which a crystal has in common with that of 3-Br; (b) XPac dissimilarity index computed from intermolecular geometrical parameters which were calculated using the ten non-H atomic positions of the common salicylic acid molecular fragment; (c) the length of the X11 stacking vector.

Other noteworthy packing relationships exist between 3-Br and the structures of 3,5-Br (XISGEM; Liu et al., 2008) and 3,5-Cl (WECXAE; Gao et al., 2005). These are based on the sheet structure which lies parallel to (10Inline graphic) in the 3-Br crystal and is depicted in Fig. 3 a. The corresponding x 10 values of 11.8 and 12.4 for this 2-periodic SC [denoted S2 in Fig. 5(left)] indicate a relaxed form of geometrical similarity, which is consistent with the accommodation of additional halogen substituents in the planes of 3,5-Cl and 3,5-Br. Moreover, the short C4—H4⋯O1 contact found in 3-Br (see above) is replaced by other close contacts in the S2 instances of 3,5-Br and 3,5-Cl. Table S2 of the Supporting information contains the corresponding crystallographic parameters associated with SC S2. A graphical overview of the packing relationships involving 3-Br and their inter­dependencies is given in Fig. 5(left).

Synthesis and crystallization  

The title compound was prepared from 5-sulfosalicylic acid by bromination, followed by desulfonation in hot phospho­ric acid and, finally, purification by steam distillation, as described by Meldrum & Shah (1923). Single crystals were obtained by recrystallisation from hot water.

1H NMR (DMSO-d 6, 300 MHz): 6.87 (t, J = 7.9 Hz, 1H), 5.3 (br, 1H), 7.80 (d, J = 7.9 Hz, 2H), 11.5 (br, 1H) p.p.m. 13C NMR (DMSO-d 6, 75 MHz): 110.1, 114.3, 120.2 (CH), 129.7 (CH), 138.5 (CH), 157.6, 171.6 p.p.m. 1H NMR (CDCl3, 300 MHz): 6.85 (t, J = 7.9 Hz, 1H), 7.79 (dd, J = 7.9 and 1.6 Hz, 1H), 7.92 (dd, J = 7.9 and 1.6 Hz, 1H), 11.07 (s, 1H) p.p.m. 13C NMR (CDCl3, 75 MHz): 111.8, 112.8, 120.7 (CH), 130.6 (CH), 140.5 (CH), 159.0, 174.1 p.p.m. IR (neat): 2855, 2526, 1653, 1603, 1428, 1298, 1243, 1153, 851, 744, 677, 469 cm−1.

Refinement  

Crystal data, data collection and structure refinement details are summarized in Table 3. Positions of hydrogen atoms bonded to carbon atoms were generated in idealized geometries using a riding model and their displacement parameters were set to U iso(H) = 1.2 U eq(C). The H atoms attached to O were identified from difference Fourier maps and their positions refined with restrained distances [O—H 0.86 (2) Å] and their isotropic thermal displacement parameters were refined freely.

Table 3. Experimental details.

Crystal data
Chemical formula C7H5BrO3
M r 217.02
Crystal system, space group Monoclinic, P21/n
Temperature (K) 173
a, b, c () 3.7978(4), 10.5567(6), 18.0366(10)
() 90.208(7)
V (3) 723.12(10)
Z 4
Radiation type Mo K
(mm1) 5.63
Crystal size (mm) 0.32 0.16 0.08
 
Data collection
Diffractometer Agilent Xcalibur (Ruby, Gemini ultra)
Absorption correction Multi-scan (CrysAlis PRO; Agilent, 2012)
T min, T max 0.094, 1
No. of measured, independent and observed [I > 2(I)] reflections 4627, 1594, 1309
R int 0.040
(sin /)max (1) 0.684
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.040, 0.100, 1.08
No. of reflections 1594
No. of parameters 108
No. of restraints 2
H-atom treatment H atoms treated by a mixture of independent and constrained refinement
max, min (e 3) 1.19, 0.79

Computer programs: CrysAlis PRO (Agilent, 2012), SUPERFLIP (Palatinus Chapuis, 2007), SHELXL2014 (Sheldrick, 2015), ORTEP-3 for Windows and WinGX (Farrugia, 2012), Mercury (Macrae et al., 2006), XP (Sheldrick, 2008) and publCIF (Westrip, 2010).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015007331/wm5143sup1.cif

e-71-00531-sup1.cif (169.6KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015007331/wm5143Isup2.hkl

e-71-00531-Isup2.hkl (87.9KB, hkl)

Supporting information file. DOI: 10.1107/S2056989015007331/wm5143Isup3.pdf

e-71-00531-Isup3.pdf (112.9KB, pdf)

Supporting information file. DOI: 10.1107/S2056989015007331/wm5143Isup4.cml

CCDC reference: 1059331

Additional supporting information: crystallographic information; 3D view; checkCIF report

supplementary crystallographic information

Crystal data

C7H5BrO3 F(000) = 424
Mr = 217.02 Dx = 1.993 Mg m3
Monoclinic, P21/n Mo Kα radiation, λ = 0.71073 Å
a = 3.7978 (4) Å Cell parameters from 1701 reflections
b = 10.5567 (6) Å θ = 3.0–28.1°
c = 18.0366 (10) Å µ = 5.63 mm1
β = 90.208 (7)° T = 173 K
V = 723.12 (10) Å3 Plate, colourless
Z = 4 0.32 × 0.16 × 0.08 mm

Data collection

Agilent Xcalibur (Ruby, Gemini ultra) diffractometer 1594 independent reflections
Radiation source: Enhance (Mo) X-ray Source 1309 reflections with I > 2σ(I)
Graphite monochromator Rint = 0.040
Detector resolution: 10.3575 pixels mm-1 θmax = 29.1°, θmin = 3.0°
ω scans h = −4→3
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2012) k = −12→10
Tmin = 0.094, Tmax = 1 l = −21→19
4627 measured reflections

Refinement

Refinement on F2 Primary atom site location: iterative
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.040 Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.100 H atoms treated by a mixture of independent and constrained refinement
S = 1.08 w = 1/[σ2(Fo2) + (0.0507P)2 + 0.2934P] where P = (Fo2 + 2Fc2)/3
1594 reflections (Δ/σ)max < 0.001
108 parameters Δρmax = 1.19 e Å3
2 restraints Δρmin = −0.79 e Å3

Special details

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
Br1 0.28846 (10) 0.31635 (3) 0.19518 (2) 0.02717 (17)
O2 0.9783 (9) 0.1747 (2) 0.51138 (16) 0.0323 (7)
H2 1.055 (16) 0.109 (4) 0.535 (3) 0.08 (2)*
O1 0.5137 (8) 0.1225 (2) 0.30358 (15) 0.0304 (7)
H1 0.574 (15) 0.064 (4) 0.334 (3) 0.060 (16)*
O3 0.7802 (8) 0.0380 (2) 0.42729 (15) 0.0330 (7)
C3 0.4674 (10) 0.3437 (3) 0.2917 (2) 0.0214 (8)
C2 0.5652 (10) 0.2381 (3) 0.3340 (2) 0.0216 (8)
C1 0.7081 (10) 0.2576 (3) 0.4042 (2) 0.0214 (8)
C7 0.8233 (10) 0.1476 (4) 0.4484 (2) 0.0241 (8)
C4 0.5058 (10) 0.4649 (3) 0.3191 (2) 0.0251 (8)
H4 0.4369 0.5356 0.2899 0.030*
C6 0.7467 (10) 0.3806 (3) 0.4318 (2) 0.0242 (8)
H6 0.8432 0.3935 0.4799 0.029*
C5 0.6454 (11) 0.4832 (4) 0.3896 (2) 0.0284 (9)
H5 0.6711 0.5666 0.4087 0.034*

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
Br1 0.0292 (3) 0.0333 (3) 0.0190 (3) 0.00063 (15) −0.00907 (17) 0.00363 (14)
O2 0.049 (2) 0.0296 (16) 0.0187 (16) 0.0017 (12) −0.0129 (14) 0.0054 (11)
O1 0.0443 (19) 0.0232 (15) 0.0234 (16) 0.0006 (12) −0.0131 (13) 0.0003 (11)
O3 0.049 (2) 0.0252 (15) 0.0250 (16) 0.0053 (12) −0.0134 (13) 0.0000 (11)
C3 0.019 (2) 0.034 (2) 0.0118 (19) 0.0021 (15) −0.0018 (15) 0.0026 (14)
C2 0.0177 (19) 0.027 (2) 0.020 (2) −0.0001 (14) −0.0004 (15) 0.0025 (14)
C1 0.0155 (19) 0.030 (2) 0.018 (2) 0.0012 (14) 0.0004 (15) 0.0031 (14)
C7 0.022 (2) 0.035 (2) 0.015 (2) 0.0033 (15) −0.0009 (16) 0.0018 (15)
C4 0.023 (2) 0.027 (2) 0.026 (2) 0.0009 (15) −0.0025 (17) 0.0022 (15)
C6 0.026 (2) 0.028 (2) 0.018 (2) −0.0012 (15) −0.0051 (16) −0.0004 (14)
C5 0.033 (2) 0.020 (2) 0.031 (2) −0.0008 (15) −0.0031 (18) −0.0001 (14)

Geometric parameters (Å, º)

Br1—C3 1.889 (4) C2—C1 1.391 (5)
O2—C7 1.309 (5) C1—C6 1.398 (6)
O2—H2 0.87 (2) C1—C7 1.474 (5)
O1—C2 1.352 (5) C4—C5 1.388 (6)
O1—H1 0.85 (2) C4—H4 0.9500
O3—C7 1.229 (5) C6—C5 1.379 (5)
C3—C4 1.379 (5) C6—H6 0.9500
C3—C2 1.400 (5) C5—H5 0.9500
C7—O2—H2 114 (4) O3—C7—C1 122.4 (3)
C2—O1—H1 111 (4) O2—C7—C1 115.4 (3)
C4—C3—C2 121.0 (4) C3—C4—C5 119.8 (3)
C4—C3—Br1 120.7 (3) C3—C4—H4 120.1
C2—C3—Br1 118.3 (3) C5—C4—H4 120.1
O1—C2—C1 123.9 (3) C5—C6—C1 120.3 (4)
O1—C2—C3 117.4 (3) C5—C6—H6 119.9
C1—C2—C3 118.7 (3) C1—C6—H6 119.9
C2—C1—C6 120.1 (3) C6—C5—C4 120.1 (3)
C2—C1—C7 119.3 (3) C6—C5—H5 120.0
C6—C1—C7 120.6 (3) C4—C5—H5 120.0
O3—C7—O2 122.2 (3)
C4—C3—C2—O1 178.9 (4) C6—C1—C7—O3 176.9 (4)
Br1—C3—C2—O1 −2.2 (5) C2—C1—C7—O2 175.1 (3)
C4—C3—C2—C1 −1.0 (6) C6—C1—C7—O2 −3.8 (5)
Br1—C3—C2—C1 177.9 (3) C2—C3—C4—C5 0.4 (6)
O1—C2—C1—C6 −178.9 (3) Br1—C3—C4—C5 −178.5 (3)
C3—C2—C1—C6 1.0 (5) C2—C1—C6—C5 −0.3 (6)
O1—C2—C1—C7 2.1 (6) C7—C1—C6—C5 178.6 (4)
C3—C2—C1—C7 −178.0 (3) C1—C6—C5—C4 −0.3 (6)
C2—C1—C7—O3 −4.2 (6) C3—C4—C5—C6 0.3 (6)

Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
O1—H1···O3 0.85 (2) 1.88 (4) 2.604 (4) 142 (5)
O2—H2···O3i 0.87 (2) 1.80 (2) 2.664 (4) 172 (6)

Symmetry code: (i) −x+2, −y, −z+1.

References

  1. Adam, M. S., Gutmann, M. J., Leech, C. K., Middlemiss, D. S., Parkin, A., Thomas, L. H. & Wilson, C. C. (2010). New J. Chem. 34, 85–91.
  2. Agilent (2012). CrysAlis PRO. Agilent Technologies, Yarnton, England.
  3. Bawa, S., Coté, M. L., Dubois, P., Lalancette, R. A. & Thompson, H. W. (2004). Acta Cryst. B60, 438–446. [DOI] [PubMed]
  4. Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555–1573.
  5. Braun, D. E., Karamertzanis, P. G., Arlin, J.-B., Florence, A. J., Kahlenberg, V., Tocher, D. A., Griesser, U. J. & Price, S. L. (2011). Cryst. Growth Des. 11, 210–220. [DOI] [PMC free article] [PubMed]
  6. Choudhury, A. R. & Guru Row, T. N. (2004). Acta Cryst. E60, o1595–o1597. [DOI] [PubMed]
  7. Claude, R., Zarembowitch, J., Philoche-Levisalles, M. & D’Yvoire, F. (1991). New J. Chem. 15, 635–641.
  8. Cox, P. J. & Murphy, M. T. (2003). Acta Cryst. E59, o1108–o1110.
  9. Eijgendaal, I., Klein, G., Ter Horst-Van Amstel, M. J. L., Zwier, K., Bruins, N., Rigter, H. T. & Gout, E. (2006). US Patent 0040932 A1.
  10. Etter, M. C., MacDonald, J. C. & Bernstein, J. (1990). Acta Cryst. B46, 256–262. [DOI] [PubMed]
  11. Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.
  12. Gao, Z.-W., Zhang, C.-Y., Gao, L.-X., Wang, G.-F., Wu, D.-H. & Liu, Z.-T. (2005). Z. Kristallogr. New Cryst. Struct. 220, 553–554.
  13. Gelbrich, T. & Hursthouse, M. B. (2005). CrystEngComm, 7, 324–336.
  14. Gelbrich, T., Threlfall, T. L. & Hursthouse, M. B. (2012). CrystEngComm, 14, 5454–5464.
  15. Groom, C. R. & Allen, F. H. (2014). Angew. Chem. Int. Ed. 53, 662–671. [DOI] [PubMed]
  16. Laus, G., Kahlenberg, V., Wurst, K., Nerdinger, S. & Schottenberger, H. (2011). Z. Naturforsch. Teil B, 66, 479–486.
  17. Li, J.-H., Dong, F.-Y., Cai, F., Yuan, X.-F. & Jiang, R.-W. (2012). Acta Cryst. E68, o825–o826. [DOI] [PMC free article] [PubMed]
  18. Liu, C.-B., Chen, D.-D. & Wen, H.-L. (2008). Acta Cryst. E64, o3. [DOI] [PMC free article] [PubMed]
  19. Lu, Y.-B., Yang, P., Huang, W.-N., Yang, Y.-N. & Wu, J.-Z. (2010). Acta Cryst. C66, o596–o599. [DOI] [PubMed]
  20. Macrae, C. F., Edgington, P. R., McCabe, P., Pidcock, E., Shields, G. P., Taylor, R., Towler, M. & van de Streek, J. (2006). J. Appl. Cryst. 39, 453–457.
  21. Meldrum, A. N. & Shah, M. S. (1923). J. Chem. Soc. Trans. 123, 1986–1993.
  22. Mereiter, K., Mikenda, W. & Reichl, G. (2001). Private communication (refcode: IBUMAT). CCDC, Cambridge, England.
  23. Montis, R. & Hursthouse, M. B. (2012). CrystEngComm, 14, 5242–5254.
  24. Palatinus, L. & Chapuis, G. (2007). J. Appl. Cryst. 40, 786–790.
  25. Parkin, A., Adam, M., Cooper, R. I., Middlemiss, D. S. & Wilson, C. C. (2007). Acta Cryst. B63, 303–308. [DOI] [PubMed]
  26. Sarma, B., Sanphui, P. & Nangia, A. (2010). Cryst. Growth Des. 10, 2388–2399.
  27. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  28. Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
  29. Talberg, H. J. (1977). Acta Chem. Scand. Ser. A, 31, 485–491.
  30. Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.
  31. Zwier, K., Klein, G., Eijgendaal, I. & Ter Horst-Van Amstel, M. J. L. (2005). Int. Patent WO 016898 A2.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015007331/wm5143sup1.cif

e-71-00531-sup1.cif (169.6KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015007331/wm5143Isup2.hkl

e-71-00531-Isup2.hkl (87.9KB, hkl)

Supporting information file. DOI: 10.1107/S2056989015007331/wm5143Isup3.pdf

e-71-00531-Isup3.pdf (112.9KB, pdf)

Supporting information file. DOI: 10.1107/S2056989015007331/wm5143Isup4.cml

CCDC reference: 1059331

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES